Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Molecular Fluorescence Imaging”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Testing effectiveness (Phase 2)Looking for participantsNCT03938701
What this trial is testing

Fluorescence Imaging of IBD and RA Using Adalimumab-800CW

Who this might be right for
IBDRheumatoid Arthritis
University Medical Center Groningen 36
Testing effectiveness (Phase 2)Looking for participantsNCT06606808
What this trial is testing

Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease

Who this might be right for
Ulcerative Colitis (UC)Crohn Disease (CD)
University Medical Center Groningen 18
Testing effectiveness (Phase 2)Looking for participantsNCT07276789
What this trial is testing

Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Patients Undergoing Lung Cancer Resection for Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
Integro Theranostics 35
Very early researchStudy completedNCT02901925
What this trial is testing

A Microdose Evaluation Study of ABY-029 in Recurrent Glioma

Who this might be right for
Glioma
Dartmouth-Hitchcock Medical Center 14
Not applicableLooking for participantsNCT07498933
What this trial is testing

FAP-targeted PET/NIR in Lung Malignant Tumors

Who this might be right for
Non-Small Cell Lung CancerPET/CTNeoadjuvant Therapy
Peking University People's Hospital 200
Early research (Phase 1)Looking for participantsNCT05725876
What this trial is testing

Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis.

Who this might be right for
PsoriasisCrohn Disease
University Medical Center Groningen 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06809946
What this trial is testing

Feasibility of Fluorescence Imaging With Bevacizumab-800CW During Bronchoscopy

Who this might be right for
Lung NeoplasmsPulmonary NeoplasmsLymph Node Involvement+1 more
University Medical Center Groningen 20
Very early researchStudy completedNCT03154411
What this trial is testing

A Microdose Evaluation Study of ABY-029 in Primary Sarcoma

Who this might be right for
Primary Soft-tissue Sarcoma
Dartmouth-Hitchcock Medical Center 12
Early research (Phase 1)Study completedNCT06095362
What this trial is testing

Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CW

Who this might be right for
Thyroid CarcinomaSurgery
University Medical Center Groningen 20
Early research (Phase 1)Study completedNCT01508572
What this trial is testing

VEGF-targeted Fluorescent Tracer Imaging in Breast Cancer

Who this might be right for
Breast Cancer
University Medical Center Groningen 20
Early research (Phase 1)UnknownNCT03925285
What this trial is testing

Image Guided Surgery in Sinonasal Inverted Papilloma

Who this might be right for
Inverted PapillomaMolecular Fluorescence Imaging
University Medical Center Groningen 6
Not applicableLooking for participantsNCT07419178
What this trial is testing

A New Diagnostic Algorithm to Non-invasively Track Fibrotic Changes in Myeloproliferative Neoplasms Based on C-C Chemokine Receptor 2 Detection. From Flow Cytometry to the Development of Targeted Positron Emission Tomography Molecular Imaging. Pre-clinical Studies and First In-human Proof of Concept

Who this might be right for
Myelofibrosis (MF)
Azienda Ospedaliero-Universitaria di Parma 265
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07258641
What this trial is testing

Fluorescence Imaging of Adalimumab-680LT and Risankizumab-800CW in Inflammatory Bowel Disease

Who this might be right for
Ulcerative Colitis (UC)Crohn Disease (CD)
University Medical Center Groningen 30
Not applicableUnknownNCT06447181
What this trial is testing

Application of Three- Dimensional Visualization Combined With ICG Molecular Fluorescence Imaging in Hepatolithiasis

Who this might be right for
HepatolithiasisHepatectomy
Zhujiang Hospital 100
Early research (Phase 1)Study completedNCT01873716
What this trial is testing

Indocyanine Green Fluorescence Uptake in Human Carotid Artery Plaque

Who this might be right for
AtherosclerosisAtherosclerotic PlaqueCarotid Stenosis
Massachusetts General Hospital 5
Testing effectiveness (Phase 2)UnknownNCT03134846
What this trial is testing

Image Guided Surgery for Margin Assessment of Head and Neck Cancer Using Cetuximab-IRDye800CW cONjugate

Who this might be right for
Head and Neck Squamous Cell CarcinomaMargin Assessment
University Medical Center Groningen 79
Early research (Phase 1)UnknownNCT02975219
What this trial is testing

Feasibility Study of Using Molecular Fluorescence Guided Surgery in Endometriosis

Who this might be right for
Endometriosis
University Medical Center Groningen 10
Testing effectiveness (Phase 2)UnknownNCT05043519
What this trial is testing

Phase I/II Clinical Trial of NP41 for Cranial Nerve Fluorescence Imaging

Who this might be right for
Cranial Nerve Injuries
Peking University Third Hospital 40
Post-approval studies (Phase 4)Not Yet RecruitingNCT07469202
What this trial is testing

CYTALUX Dose Extension Study

Who this might be right for
Cancer in the LungOvarian Cancer
On Target Laboratories, LLC 106
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07653438
What this trial is testing

In Vivo Fluorescence Molecular Bronchoscopy of Durvalumab-680LT in Patients With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) After Chemoradiotherapy

Who this might be right for
Stage III Non-small Cell Lung CancerUnresectable Stage III NSCLC
University Medical Center Groningen 20
Next Page